This track focuses on the latest advancements in cancer treatment methodologies, including targeted therapies and combination treatments. Participants will explore the efficacy and safety of novel agents in clinical practice.

This session emphasizes the importance of translating laboratory discoveries into clinical applications in oncology. Discussions will center on the challenges and successes of implementing innovative research findings in patient care.

This track examines the role of precision medicine in tailoring cancer treatment to individual patient profiles. Topics will include genomic profiling, biomarker identification, and personalized therapeutic strategies.

This session will delve into the latest developments in immunotherapy for cancer treatment, including checkpoint inhibitors and CAR T-cell therapy. Participants will discuss clinical outcomes and the future landscape of immunotherapeutic approaches.

This track will explore the underlying biological mechanisms of cancer development and progression. Emphasis will be placed on innovative research that uncovers new targets for therapeutic intervention.

This session focuses on the integration of patient perspectives into cancer care practices. Discussions will include strategies for enhancing patient engagement, communication, and overall quality of care.